Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparison of T Cell Activities Mediated by Human TCRs and CARs That Use the Same Recognition Domains
Daniel T. Harris, Marlies V. Hager, Sheena N. Smith, et al.
The Journal of Immunology (2017) Vol. 200, Iss. 3, pp. 1088-1100
Open Access | Times Cited: 151

Showing 1-25 of 151 citing articles:

Tumor Antigen Escape from CAR T-cell Therapy
Robbie G. Majzner, Crystal L. Mackall
Cancer Discovery (2018) Vol. 8, Iss. 10, pp. 1219-1226
Open Access | Times Cited: 861
Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
Mohamed-Reda Benmebarek, Clara H. Karches, Bruno L. Cadilha, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 6, pp. 1283-1283
Open Access | Times Cited: 419
Tuning the Antigen Density Requirement for CAR T-cell Activity
Robbie G. Majzner, Skyler P. Rietberg, Elena Sotillo, et al.
Cancer Discovery (2020) Vol. 10, Iss. 5, pp. 702-723
Open Access | Times Cited: 415
Navigating CAR-T cells through the solid-tumour microenvironment
Andrew J. Hou, Laurence C. Chen, Yvonne Y. Chen
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 7, pp. 531-550
Open Access | Times Cited: 370
The Emerging Landscape of Immune Cell Therapies
Evan W. Weber, Marcela V. Maus, Crystal L. Mackall
Cell (2020) Vol. 181, Iss. 1, pp. 46-62
Open Access | Times Cited: 362
CAR immune cells: design principles, resistance and the next generation
Louai Labanieh, Crystal L. Mackall
Nature (2023) Vol. 614, Iss. 7949, pp. 635-648
Closed Access | Times Cited: 338
T cell receptor‐based cancer immunotherapy: Emerging efficacy and pathways of resistance
Smita S. Chandran, Christopher A. Klebanoff
Immunological Reviews (2019) Vol. 290, Iss. 1, pp. 127-147
Open Access | Times Cited: 255
CAR-T design: Elements and their synergistic function
Jayapriya Jayaraman, Michael Mellody, Andrew J. Hou, et al.
EBioMedicine (2020) Vol. 58, pp. 102931-102931
Open Access | Times Cited: 248
Genetically engineered T cells for cancer immunotherapy
Dan Li, Xue Li, Weilin Zhou, et al.
Signal Transduction and Targeted Therapy (2019) Vol. 4, Iss. 1
Open Access | Times Cited: 205
Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects
Paul Shafer, Lauren Kelly, Valentina Hoyos
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 151
The Emerging World of TCR-T Cell Trials Against Cancer: A Systematic Review
Jianxiang Zhang, Lingyu Wang
Technology in Cancer Research & Treatment (2019) Vol. 18
Open Access | Times Cited: 149
Targeting public neoantigens for cancer immunotherapy
Alexander H. Pearlman, Michael S. Hwang, Maximilian F. Konig, et al.
Nature Cancer (2021) Vol. 2, Iss. 5, pp. 487-497
Open Access | Times Cited: 130
Chimeric STAR receptors using TCR machinery mediate robust responses against solid tumors
Yue Liu, Guangna Liu, Jiasheng Wang, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 586
Closed Access | Times Cited: 111
Comparative analysis of TCR and CAR signaling informs CAR designs with superior antigen sensitivity and in vivo function
Alexander I. Salter, Anusha Rajan, Jacob J. Kennedy, et al.
Science Signaling (2021) Vol. 14, Iss. 697
Open Access | Times Cited: 107
Cell-based drug delivery systems and their in vivo fate
Liuxin Yang, Yang Yang, Yang Chen, et al.
Advanced Drug Delivery Reviews (2022) Vol. 187, pp. 114394-114394
Closed Access | Times Cited: 83
Challenges and new technologies in adoptive cell therapy
Pengchao Zhang, Guizhong Zhang, Xiaochun Wan
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 82
Current and future concepts for the generation and application of genetically engineered CAR-T and TCR-T cells
Michael Hiltensperger, Angela M. Krackhardt
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 47
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 12
CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based Therapies
Dongrui Wang, Briana C. Prager, Ryan C. Gimple, et al.
Cancer Discovery (2020) Vol. 11, Iss. 5, pp. 1192-1211
Open Access | Times Cited: 116
Signaling from T cell receptors (TCRs) and chimeric antigen receptors (CARs) on T cells
Ling Wu, Qianru Wei, Joanna Brzostek, et al.
Cellular and Molecular Immunology (2020) Vol. 17, Iss. 6, pp. 600-612
Open Access | Times Cited: 115
A novel antibody-TCR (AbTCR) platform combines Fab-based antigen recognition with gamma/delta-TCR signaling to facilitate T-cell cytotoxicity with low cytokine release
Yiyang Xu, Zhiyuan Yang, Lucas H. Horan, et al.
Cell Discovery (2018) Vol. 4, Iss. 1
Open Access | Times Cited: 104
Mathematical deconvolution of CAR T-cell proliferation and exhaustion from real-time killing assay data
Prativa Sahoo, Xin Yang, Daniel Abler, et al.
Journal of The Royal Society Interface (2020) Vol. 17, Iss. 162, pp. 20190734-20190734
Open Access | Times Cited: 89
TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and Goals
Francesco Manfredi, Beatrice Claudia Cianciotti, Alessia Potenza, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 87
Advancing CAR T-Cell Therapy for Solid Tumors: Lessons Learned from Lymphoma Treatment
Aleksei Titov, Aygul Valiullina, Ekaterina Zmievskaya, et al.
Cancers (2020) Vol. 12, Iss. 1, pp. 125-125
Open Access | Times Cited: 82
Adoptive Immunotherapy beyond CAR T-Cells
Aleksei Titov, Ekaterina Zmievskaya, Irina Ganeeva, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 743-743
Open Access | Times Cited: 79
Page 1 - Next Page

Scroll to top